Ramkumar Mandalam
Direttore/Membro del Consiglio presso CRYOPORT, INC.
Patrimonio netto: 387 181 $ in data 30/06/2024
Posizioni attive di Ramkumar Mandalam
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CRYOPORT, INC. | Direttore/Membro del Consiglio | 16/06/2014 | - |
| Independent Dir/Board Member | 16/06/2014 | - | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Direttore/Membro del Consiglio | 20/10/2010 | - |
| Amministratore Delegato | 01/01/2005 | - | |
| Presidente | 01/01/2005 | - | |
Stempeutics Research Pvt. Ltd.
 Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Direttore/Membro del Consiglio | - | - |
| Citra Bioconsulting, Inc. | Amministratore Delegato | 01/01/2021 | - |
| Fondatore | 01/01/2021 | - |
Storia della carriera di Ramkumar Mandalam
Precedenti posizioni note di Ramkumar Mandalam
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VERICEL CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/1994 | 01/01/2000 |
| Corporate Officer/Principal | 01/01/1994 | 01/01/2000 | |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Ramkumar Mandalam
| University of Michigan | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| India | 2 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
| Transportation | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GERON CORPORATION | Health Technology |
| VERICEL CORPORATION | Health Technology |
| CRYOPORT, INC. | Transportation |
| Aziende private | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
| Citra Bioconsulting, Inc. |
- Borsa valori
- Insiders
- Ramkumar Mandalam
- Esperienza
